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Immunoglobulin (Ig) A in the mucus of the intestinal tract plays an important role in preventing the invasion of 
pathogenic microorganisms and regulating the composition of the gut microbiota. Several strains of probiotic lactic acid 
bacteria (LAB) are known to promote intestinal IgA production. Bacteria are also known to naturally release spherical 
membrane vesicles (MVs) that are involved in various biological functions such as quorum sensing, pathogenesis, and 
host immunomodulation. However, the production of MVs by LAB and their effects on host immunity remain poorly 
understood. In this study, we investigated the MV production by Lactobacillus sakei subsp. sakei NBRC15893 isolated 
from kimoto, the traditional seed mash used for brewing sake. MVs were separated from the culture broth of L. sakei 
NBRC15893 through filtration and density gradient ultracentrifugation and were observed by transmission electron 
microscopy. The MVs showed a spherical morphology, with a diameter of 30–400 nm, and contained proteins and nucleic 
acids. In addition, both the LAB cells and purified MVs promoted IgA production by murine Peyer’s patch cells. This 
MV- and cell-induced IgA production was suppressed by neutralization of Toll-like receptor (TLR) 2, which recognizes 
cell wall components of gram-positive bacteria, using an anti-TLR2 antibody. Collectively, our results indicate that MVs 
released from L. sakei NBRC15893 enhance IgA production by activating host TLR2 signaling through its cell wall 
components. Thus, it is important to consider novel interactions between gut microbiota and hosts via MVs, and MVs 
derived from probiotic bacteria could have promising applications as safe adjuvants.
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INTRODUCTION
The intestinal tract is equipped with multilevel barriers to 
prevent the invasion of pathogenic microorganisms, including 
chemical barriers such as the mucus and antimicrobial 
peptides, a physical barrier created by epithelial cells, and 
a biological barrier established by intestinal microflora 
and immune cells [1]. The gut mucosal immune system is 
characterized by the production of immunoglobulin (Ig) A, 
which not only plays an important role in preventing the 
invasion of pathogenic microorganisms into epithelial cells 
[2] but also regulates the composition of the gut microbiota 
[3, 4]. Therefore, enhancement of IgA production in the gut 
through dietary components and probiotics such as lactic acid 
bacteria (LAB) and bifidobacteria can be an effective strategy 
for enhancing the immune system, thereby preventing 
infectious diseases and maintaining the optimal composition 
of the gut microbiota.
IgA production in the gut involves the induction of IgA 
class-switch recombination (CSR) in which IgM+ B cells 
change to IgA+ B cells in gut-associated lymphatic tissues, 
including Peyer’s patches (PPs). This step is followed by the 
differentiation of the IgA+ B cells into IgA-producing plasma 
cells in the intestinal mucosal lamina propria. During this 
process, CD4+ T cells, which are activated by antigen-specific 
dendritic cells (DCs), induce the IgA CSR of IgM+ B cells in 
the presence of stimuli such as transforming growth factor 
(TGF)-β, interleukin (IL)-4, and IL-6 [5]. IgA CSR is also 
induced by retinoic acid, a proliferation-inducing ligand, or 
B-cell activating factor, which are produced by DCs in the 
PPs through a route independent of T cells [6]. Indeed, several 
reports have demonstrated the IgA-enhancing effects of LAB 
strains in the gut [7], including Lactobacillus pentosus strain 
b240 [8], L. plantarum AYA [9], and L. gasseri SBT 2055 [10]. 
These strains activate DCs in the PPs via Toll-like receptors 
(TLRs) and induce the production of retinoic acid, IL-6, and 
TGF-β, which in turn enhance IgA production in vitro.
Bacteria also naturally release membrane vesicles 
(MVs) with diameters of 20–500 nm under various growth 
conditions. Although the majority of studies on MVs have 
focused on gram-negative bacteria, recent studies have also 
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reported MV production by gram-positive bacteria with thick 
peptidoglycan (PG). Moreover, the mechanism of production 
and functions of MVs have been predominantly examined 
in pathogenic strains. MVs contains bacterial components 
such as nucleic acids, proteins, and cell wall components 
and are involved in processes such as quorum sensing, relief 
of environmental stresses, delivery of pathogenic factors, 
and host immunomodulation [11–13]. For example, MVs 
produced by gram-negative bacteria Neisseria meningitidis 
[14] and Helicobacter pylori [15] act on macrophages 
to induce the inflammatory cytokine IL-6 and exert 
immunomodulatory effects. Similar mechanisms have been 
demonstrated for gram-positive bacteria. For instance, MVs 
of Mycobacteria tuberculosis inhibit the antigen presentation 
of DCs and macrophages [16], and the MVs of Clostridium 
perfringens induce IL-6 production from macrophage-like 
cells [17]. However, there are few reports on the production 
of MVs by nonpathogenic and probiotic bacteria, including 
LAB [18, 19]. The MVs of L. rhamnosus JB-1 were found to 
modulate regulatory T cells [18], and those of L. plantarum 
WCFS1 were reported to enhance the immune response 
against vancomycin-resistant enterococci [19]. Besides these 
examples, it remains unclear whether other LAB strains 
produce MVs or show immunomodulatory effects, including 
IgA-enhancing effects.
We found that the cells of Lactobacillus sakei subsp. sakei 
NBRC15893, which was isolated from kimoto, the traditional 
seed mash used for brewing sake, and the microcomponents 
obtained from the culture supernatant by ultracentrifugation 
promote IgA production from PP cells in vitro. In the present 
study, we aimed to elucidate whether L. sakei NBRC15893 
produces MVs and to identify specific microcomponents that 
mediate the IgA-enhancing effect.
MATERIALS AND METHODS
Bacterial strain and culture conditions
L. sakei subsp. sakei NBRC15893 was purchased from 
Biological Resource Center, NITE (Tokyo, Japan). The strain 
was precultured anaerobically in deMan, Rogosa and Sharpe 
(MRS) medium (Becton Dickinson and Company [BD], 
Tokyo, Japan) using an AnaeroPack system (Mitsubishi 
Gas Chemical Company, Tokyo, Japan) and then cultured 
statically in MRS medium at 30°C. The optical density at 
660 nm (OD660) of the culture broth was measured using a 
UV-1850 spectrophotometer (Shimadzu, Kyoto, Japan).
Preparation of MVs
The microcomponents in the culture broth were purified 
according to standard purification procedures for MVs [17]. 
The culture broth was centrifuged (8,500 × g, 5 min, 4°C), 
and the precipitated LAB cells were autoclaved at 121°C for 
15 min and then dried under a reduced pressure at 22–25°C. 
The supernatant was filtered (0.45 μm, Thermo Fisher 
Scientific, Waltham, MA, USA) and then ultracentrifuged 
(100,000 × g, 1 hr, 4°C). The precipitate was washed with 
10 mM HEPES containing 0.85% NaCl, pH 6.8 (hereafter 
HEPES-NaCl), and ultracentrifuged again (100,000 × g, 1 
hr, 4°C). For investigation of MV, the precipitate obtained 
from 400 ml of culture broth was resuspended in 50 µl of 
HEPES-NaCl (the suspension is hereafter referred to as the 
crude MV fraction). For purification of MVs, the precipitate 
obtained from 2.2 l of culture broth at 24 hr was suspended in 
1 ml of 45% (v/v) OptiPrep (iodixanol; Axis-Shield, Dundee, 
Scotland) in HEPES-NaCl and then overlaid by 1-ml aliquots 
of 40%, 35%, 30%, 25%, 20%, 15%, and 10% (v/v) OptiPrep 
in HEPES-NaCl. After ultracentrifugation (100,000 × g, 6 
hr, 4°C), 1.5-ml fractions were collected from the tops of the 
ultracentrifuge tubes (Fr. 1–5). Each fraction was washed with 
HEPES-NaCl by ultracentrifugation (100,000 × g, 1 hr, 4°C), 
and each precipitate was resuspended in 50 µl of the buffer.
Absorbance at 260 and 280 nm was measured using a 
NanoDrop ND-1000 system (Thermo Fisher Scientific). 
Protein concentrations were determined with a bicinchoninic 
acid protein assay reagent kit (Thermo Fisher Scientific).
Transmission electron microscopy (TEM)
Fractionated samples were stained with 2% sodium 
phosphotungstate on a collodion-coated grid (150-mesh, 
Okenshoji, Tokyo, Japan) and observed by TEM (JEM-1400, 
JOEL, Tokyo, Japan) at 80 kV.
Preparation and culture of PP cells
The experimental protocols used in this study followed the 
Guide for the Care and Use of Experimental Animals issued 
by the Prime Minister’s Office of Japan and were reviewed 
and approved by the Animal Ethics Committee of Kansai 
University (Approval No. 1706). The breeding room was 
maintained under the following conditions: temperature, 
21–23°C; humidity, 55–65%; light period, 08:00 am to 08:00 
pm. Female BALB/c mice (7–14 weeks old, Japan SLC, 
Shizuoka, Japan) were used to obtain murine PP cells. PPs 
were harvested from the small intestine of mice and then 
incubated in RPMI 1640 medium (Sigma-Aldrich, Tokyo, 
Japan) containing 0.5 mg/ml collagenase, 2% (v/v) fetal 
bovine serum (FBS; Thermo Fisher Scientific), 100 U/ml 
penicillin, and 100 µg/ml streptomycin for 30 min. The PP 
cells were filtered through a cell strainer (100 μm; BD) and 
washed with the medium without collagenase. The cells were 
suspended in RPMI 1640 medium containing 10% (v/v) FBS, 
55 µM 2-mercaptoethanol, 100 U/ml penicillin, and 100 µg/
ml streptomycin and then cultured at 1.0 × 105 cells/well 
in a U-bottom 96-well plate with or without LAB cells or 
fractionated samples for 4 days at 37°C under 5% CO2 in air.
Neutralization of TLR2 in PP cells
Murine PP cells were preincubated with 0.5 µg/ml anti-
TLR2 antibody (purified anti-mouse/human CD282, clone 
T2.5, Biolegend, San Diego, CA, USA) or isotype antibody 
(purified mouse IgG1, clone MOPC-21, Biolegend) at 37°C 
for 30 min and then cultured with or without the purified MVs 
(Fr. 3 obtained by the density gradient ultracentrifugation) or 
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L. sakei NBRC15893 (50 µg/well) cells for 4 days at 37°C 
under 5% CO2 in air.
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of IgA were determined by ELISA. In 
brief, 96-well plates (MaxiSorp; Thermo Fisher Scientific) 
were coated with 50 µl of 10 µg/ml goat anti-mouse IgA 
(Bethyl Laboratories, Montgomery, TX, USA) for 1 hr at 22–
25°C. After washing with phosphate-buffered saline (PBS) 
containing 0.05% (w/v) Tween 20, the wells were blocked 
with 300 µl PBS containing 1% bovine serum albumin 
(Sigma-Aldrich) at room temperature for 1 hr, and 50 µl of 
the diluted samples was added to each well and incubated 
at room temperature for 1 hr. After washing, 50 µl of 25 ng/
ml goat anti-mouse horseradish-peroxidase-conjugated IgA 
(Bethyl Laboratories) was added, and the wells were further 
incubated at room temperature for 1 hr. After washing, 
50 µl of the TMB microwell peroxidase substrate system 
(SeraCare, Milford, MA, USA) was added and incubated at 
room temperature. After the addition of 25 µl of 1 M sulfuric 
acid, the absorbance at 450 nm was measured using an infinite 
F200 microplate reader (Tecan, Zürich, Switzerland). Purified 
mouse IgA (κ isotype control; BD) was used as a standard.
The concentrations of IL-6 were determined by ELISA 
using a Mouse IL-6 DuoSet ELISA (R&D Systems, 
Minneapolis, MN, USA).
RESULTS
Production of MVs by L. sakei NBRC15893
To demonstrate whether L. sakei subsp. sakei NBRC15893 
produces MVs, the microcomponents in the culture 
supernatant (crude MV fraction) were first recovered by 
ultracentrifugation. The time courses of the OD660 and pH of 
the culture and the amount of protein recovered as the crude 
fraction are shown in Fig. 1. The amount of recovered protein 
increased with the increase in bacterial concentration. A 
typical TEM image of the crude MV fraction at 24 hr is shown 
in Fig. 2A. MV-like spherical structures with a diameter of 
30–400 nm, which were similar to the MVs produced by 
other bacteria, were observed. This indicated that L. sakei 
NBRC15893 releases MVs. The MVs were purified using 
a routine purification method. The protein concentrations 
and absorbance at 260 and 280 nm of each fraction (Fr. 1–5) 
obtained by density gradient ultracentrifugation are shown 
in Table 1. Brown and white bands were observed in Fr. 2 
and 3, respectively, and the protein concentration of Fr. 3 was 
higher than that of the other fractions. TEM observation of 
each fraction further revealed that the MVs were much more 
heavily concentrated in Fr. 3 than in the other fractions and 
that Fr. 2 and Fr. 4 contained only a small number of MVs 
(Fig. 2B–F). These results indicated that the MVs derived 
from L. sakei NBRC15893 contained proteins and nucleic 
acids, similar to other bacterial MVs.
IgA-enhancing effects of L. sakei NBRC15893 MVs
IgA production from the PP cells was evaluated by ELISA 
with the crude MV fraction at 24 hr and the fractions obtained 
by the density gradient ultracentrifugation. The crude MV 
fraction enhanced IgA production by the PP cells, showing 
that the microcomponents derived from L. sakei NBRC15983 
were involved in the IgA-enhancing effects. As shown in 
Fig. 3, only the IgA concentration of the cells cultured with 
Fr. 3 was significantly increased compared with that of the 
negative control group (p=0.021). These results indicated that 
MVs derived from L. sakei NBRC15893 in the culture broth 
enhanced IgA production by the PP cells.
Involvement of TLR2 in the IgA-enhancing effect of MVs
The IgA-enhancing effects of several LAB have been 
shown to be mediated by TLR2 expressed on DCs, which 
Fig. 1. Time course of the growth of L. sakei NBRC15893, pH of 
the culture broth, and MV production.
Protein concentration is expressed as the amount of protein 
obtained from 1 l of the culture supernatant.
Open circles and closed circles indicate the values of OD660 and 
pH of the culture broth in different runs, respectively. The values 
are the average of three measurements, and the measurement error 
was within approximately 5%. Repeatability was confirmed by 
repeating the experiments at least three times, and typical results 
are shown.
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recognize the cell wall components of gram-positive bacteria 
[8, 10]. Thus, the involvement of TLR2 in the IgA-enhancing 
effects of the MVs derived from L. sakei NBRC15893 and the 
LAB cells was investigated using an anti-TLR2 antibody for 
neutralization of TLR2. The increases in the IgA production 
induced by the addition of purified MVs (Fr. 3) and the LAB 
cells were completely inhibited by neutralization of TLR2 
with anti-TLR2 (Fig. 4A), indicating that both L. sakei 
NBRC15893 cells and the MVs they release enhance IgA 
production from PP cells via TLR2. In addition, since it was 
reported that several LAB strains induce IL-6 production from 
DCs [8–10], which activates B cells to produce IgA, the IL-6 
concentration in the culture supernatant was measured. MVs 
and LAB cells induced IL-6 production from PP cells, and the 
induction by MVs and LAB cells was suppressed by addition 
of anti-TLR2 antibody (p=0.071 and 0.045, respectively; Fig. 
4B), similar to that in IgA production. It was revealed that 
MVs of the strain induced IL-6 production from PP cells via 
TLR2. These results suggested that both MVs and LAB cells 
enhance IL-6 production via TLR2, resulting in promotion of 
IgA production.
DISCUSSION
We demonstrated that the nonpathogenic gram-positive 
bacterium L. sakei NBRC15893 produced MVs, which, along 
with the cells themselves, exhibit IgA-enhancing effects in PP 
cells via TLR2.
Envelope structures of gram-negative bacteria are stabilized 
via protein cross-links that reach from the inner membrane 
(IM) through the PG to the outer membrane (OM). MVs are 
produced through liberation of the OM from the covalent and 
noncovalent OM-PG-IM cross-links without concomitant 
damage and loss of membrane integrity either due to the loss 
of OM proteins, periplasmic lipoproteins, and PG or through 
the accumulation of misfolded proteins in the periplasm [20, 
21]. In addition, it has been reported that explosive cell lysis 
produces membrane fragments that rapidly form MVs through 
the activity of a cryptic prophage endolysin [22]. Although 
little is known about the mechanism of MV production of 
Fig. 2. Typical transmission electron microscope images of MVs.
(A) Crude membrane vesicle fraction precipitated by the ultracentrifugation and the fractions 
obtained by the density-gradient ultracentrifugation of the precipitate: (B) Fr. 1, (C) Fr. 2, (D) 
Fr. 3, (E) Fr. 4, (F) Fr. 5. Scale bars, 200 nm. Repeatability was confirmed by repeating the 
similar experiment at least three times, and typical results are shown.
Fig. 3. IgA-enhancing effects of fractions obtained by density 
gradient ultracentrifugation in Peyer’s patch (PP) cells.
The PP cells (1.0 × 105 cells/well) were cultured with the crude 
membrane vesicle (MV) fraction (protein concentration, 37 µg/ml) 
or equal volumes of each fraction obtained by the density-gradient 
ultracentrifugation of 10–45% (v/v) OptiPrep (one-hundredth the 
protein concentration of each fraction shown in Table 1) for 4 
days. NC, negative control. Crude, crude MV fractions. The data 
are presented as means ± standard deviations of triplicate samples. 
*p<0.05, Student’s t-test.
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gram-positive bacteria, it is predicted that an increase in the 
turgor pressure of the cytoplasm, followed by distortion of 
the cell wall, and presence of a channel that penetrates the 
cell wall result in MV release [23]. Recently, Toyofuku et 
al. reported that the cell membrane was extruded from the 
pores of PG degraded by endolysin to release MVs in Bacillus 
subtilis [24].
According to the Kyoto Encyclopedia of Genes and 
Genomes database (KEGG; http://www.genome.jp/kegg/), 
several lactobacilli such as L. plantarum WCFS1, L. casei 
BL23, L. salivarius JCM1046, and L. rhamnosus GG possess 
genes encoding endolysin. Although we did not confirm 
whether L. sakei NBRC15893 also possesses an endolysin-
encoding gene, it is possible that endolysin is also involved 
in the MV production by the LAB and that MV production is 
not limited to certain strains but occurs widely in most LAB 
strains.
Cell wall components such as lipoteichoic acid of L. 
casei YIT 9029 and L. fermentum YIT 0159 [25], teichoic 
acid of L. plantarum ATCC 14917T [26], PG of L. pentosus 
strain b240 [8] and L. casei YIT 9029 [27], and lipoprotein 
of L. acidophilus X37 [28] have been reported to exert 
immunomodulatory effects via TLR2. MVs generally contain 
these cell wall components in addition to nucleic acids and 
proteins. For example, the lipoproteins contained in the 
MVs of M. tuberculosis were shown to inhibit the antigen 
presentation of DCs and macrophages via TLR2 [16], and 
components considered to be lipoproteins contained in the 
MVs of C. perfringens also induced the IL-6 production of 
macrophage-like cells [17]. Here, we found that the whole 
cells of L. sakei NBRC15893 also enhanced IgA production 
via TLR2 signaling, suggesting that IgA production by the 
MVs may be stimulated by the TLR2 ligands that are derived 
from the cells and also contained in the MVs.
Regarding the induction of IgA production from PP cells, 
it has been reported that several LAB cells produce IL-6 
and other cytokines via TLR2 of DCs [8–10], resulting 
in activation of B cells promoting IgA production. In this 
study, it was suggested that IL-6 induced by MVs of L. sakei 
NBRC15893 promote IgA production as well as the LAB 
cells. It is necessary to clarify the detailed mechanism of the 
IgA-enhancing effect of MVs derived from the strain.
Furthermore, the MVs of L. sakei NBRC15893 may be 
taken up by PP cells in vivo, resulting in enhancement of IgA 
production in the gut, as Al-Nedawi et al. [18] demonstrated 
that MVs were taken into the DCs of the PP after oral 
administration of the MVs derived from L. rhamnosus JB-1. 
With increasing recognition of the influence of gut microbiota 
on health and diseases of the host, the finding that LAB in 
the host microbiota produce MVs with immunomodulatory 
effects, including an IgA-enhancing effect, indicates an 
important role of MVs in mediating interactions between 
the host and bacteria. Moreover, MVs are frequently isolated 
from biofilms and have been related to the aggregation 
of bacteria and biofilm formation [29, 30]. When LAB are 
used as probiotics, they are expected to become established 
in the intestinal tract of the host. Since the aggregation of 
bacterial cells is an important step leading to the successful 
establishment [31], gaining a detailed understanding of 
the mechanism of MV production and its functions is very 
important to ensure a beneficial effect.
In summary, we found that the MVs of L. sakei 
NBRC15893 could activate the mucosal immune system 
Table 1. Concentrations of cytoplasmic constituents of fractions 
obtained by density gradient ultracentrifugation
Fraction No.   Protein (mg/ml) A260 A280
1 0.02 0.07 0.02
2 0.11 0.29 0.14
3 3.42 1.59 0.92
4 0.30 1.26 0.76
5 0.01 0.53 0.11
The values are the average of three measurements, and the measure-
ment error was within approximately 5%. Repeatability was con-
firmed by repeating the experiments at least three times, and typical 
results are shown.
Fig. 4. Involvement of TLR2 in the IgA-enhancing effects of the 
purified MVs and the cells of L. sakei NBRC15893.
Peyer’s patch (PP) cells (1.0 × 105 cells/well) were cultured in the 
presence or absence of the anti-TLR2 antibody for 4 days with 
or without the MVs (protein concentration; 34 µg/ml) or L. sakei 
NBRC15893 cells (50 µg/ml). (A) IgA concentration and (B) IL-6 
concentration in the culture supernatant was measured by ELISA. 
The data are expressed as means ± standard deviations of triplicate 
samples. *p<0.05, Student’s t-test.
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via enhanced IgA production. Moreover, antigen-specific 
secretion of IgA to the mucosal surface can be induced by the 
nasal immunization of MVs derived from pathogenic bacteria 
such as Porphyromonas gingivalis, indicating that MVs are 
effective agents for the control of the mucosal immune system 
[32]. Our findings highlight the potential of the application of 
MVs derived from probiotics with established safety based 
on food experience for overall health benefits via control of 
the mucosal immune system and their potential as a vaccine 
adjuvant via the mucosa.
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